Burn Patients
8
1
2
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
12.5%
1 terminated out of 8 trials
83.3%
-3.3% vs benchmark
25%
2 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 5 completed trials
Clinical Trials (8)
Effect of Psychosocial Intervention on Body Image, Self Esteem, Burn Anxiety and Depression Among Patients With Burn
Comfort Communication Model Intervention for Burn Pain and Pain Anxiety
Pharmacokinetics Ertapenem Burns
Hologram Burn Dressing on Pain, Anxiety, Fear, Patient Satisfaction, and Physiological Parameters
Mesenchymal Stem Cells in the Treatment of Burn Wounds
Amikacin Pharmacokinetic Profile in Plasma and Tissue After an Administration Using Impregnated Dressings in Burned Patient Population
The Effectiveness of Deep Breathing Exercises and Incentive Spirometry in Second Degree Inhalation Burn Patients
Soluble Factors in the Serum of Severely Burned Patients